Oncotarget Issues Research Articles in Vol. 13, No. 1
January 10, 2022
January 10, 2022
ORCHARD PARK, New York, Jan. 10 -- Oncotarget, a peer-reviewed journal that says it encompasses all molecules, pathways, cellular functions, cell types and even tissues that can be viewed as targets relevant to cancer as well as other diseases, published research articles on the following topics in its Vol. 13, No. 1 edition:
Research Papers:
* Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non . . .
Research Papers:
* Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non . . .
